Literature DB >> 5707796

Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat.

R J Cenedella, J J Jarrell, L H Saxe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5707796     DOI： 10.1016/s0368-1319(68)80004-3

Source DB:  PubMed          Journal:  J Atheroscler Res        ISSN： 0368-1319


× No keyword cloud information.
  5 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 2.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Inducing effect of clofibrate on alkaline phosphatase and histidine-glyoxylate aminotransferase in rat liver.

Authors:  L F Panchenko; S V Popova; V D Antonenkov
Journal:  Experientia       Date:  1982-04-15

4.  Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

Authors:  B M Wolfe; J P Kane; R J Havel; H P Brewster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

5.  Inhibition of hepatic triglyceride formation by clofibrate.

Authors:  L L Adams; W W Webb; H J Fallon
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.